| Detected | Trial | Change |
|---|---|---|
| 2026-06-11 | NCT06835569 A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With… |
Enrollment increased: 188 -> 448 participants |
| 2026-06-11 | NCT06835569 A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With… |
Trial arms changed: 2 -> 10 |
| 2026-06-03 | NCT06917079 BBO-11818 in Adult Subjects With KRAS Mutant Cancer |
Primary endpoint(s) modified |
| 2026-06-03 | NCT06917079 BBO-11818 in Adult Subjects With KRAS Mutant Cancer |
Enrollment increased: 387 -> 665 participants |
| 2026-06-03 | NCT06917079 BBO-11818 in Adult Subjects With KRAS Mutant Cancer |
Trial arms changed: 14 -> 20 |
| 2026-06-03 | NCT06917079 BBO-11818 in Adult Subjects With KRAS Mutant Cancer |
Trial sites expanded: 11 -> 17 locations |
| 2026-05-28 | NCT05052801 Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth… |
Trial completed |
| 2026-05-28 | NCT05052801 Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth… |
date change Completion moved earlier: 2026-06-20 -> 2026-04-26 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07446465 | FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion… | Colorectal Cancer (Locally Advanced or Metastatic) | Not Yet Recruiting |
| Phase 3 | |||
| NCT07188025 | ctDNA-Based Adjuvant Chemotherapy for High-Risk Rectal Cancer | Rectal Cancer | Recruiting |
| NCT07549399 | SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC | Rectal Adenocarcinoma | Not Yet Recruiting |
| NCT04793958 | Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced… | Advanced Colorectal Cancer | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT06758830 | Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. | Rectal Cancer | Recruiting |
| Phase 2 | |||
| NCT06162650 | Total Neoadjuvant Therapy in Rectal Cancer | Rectal Cancer | Recruiting |
| NCT03921684 | Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients | Rectal Cancer | Active, Not Recruiting |
| NCT07381400 | Neoadjuvant mFOLFOX6 Chemotherapy Combined With Anti-PD-1 Therapy in MSS/pMMR Locally… | Rectal Cancer | Not Yet Recruiting |
| NCT05673772 | Preoperative Sequential Short-course Radiation Therapy and FOLFOX for Locally Advanced… | Rectal Cancer | Active, Not Recruiting |
| NCT07450183 | Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1 | Lung Cancer (NSCLC) | Not Yet Recruiting |
| NCT06890624 | mFOLFOXIRI Plus PD-1 Inhibitor vs mFOLFOX6 as Neoadjuvant Therapy for Locally Advanced… | Colon Cancer (Stage II &Amp;Amp; III) | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06445062 | Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors | Colorectal Cancer | Recruiting |
| NCT06324357 | Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in… | Metastatic Breast Cancer | Recruiting |
| Phase 1 | |||
| NCT06917079 | BBO-11818 in Adult Subjects With KRAS Mutant Cancer | Non-Small Cell Lung Cancer | Recruiting |
| NCT06835569 | A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With… | Cancer | Recruiting |
| NCT07543471 | A Phase I Multicentre Randomized Double-Blind Parallel-Controlled Study of HLX05-N vs… | mCRC | Not Yet Recruiting |
| Not specified | |||
| NCT03748485 | Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies… | Colorectal Cancer | Recruiting |
| NCT07413146 | Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated… | Minimal Residual Disease | Not Yet Recruiting |